Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bezard

Showing results (181-190 of 298) with videos related to

Pageof 30
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2018
An mGlu4-Positive Allosteric Modulator Alleviates Parkinsonism in PrimatesDelphine Charvin, Therese Di Paolo, Erwan Bezard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's diseaseNikhil M Urs, Simone Bido, Sean M Peterson, et al.
Biological Psychiatry|June 2, 2009
Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson diseaseOlivier Berton, Céline Guigoni, Qin Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2003
Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's diseaseCaroline Prunier, Pierre Payoux, Denis Guilloteau, et al.
Neurobiology of Disease|January 26, 2016
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's diseaseLudovico Arcuri, Riccardo Viaro, Simone Bido, et al.
Plos One|October 23, 2010
Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primateQuentin Barraud, Ibrahim Obeid, Incarnation Aubert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2012
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegenerationBenjamin Dehay, Alfredo Ramirez, Marta Martinez-Vicente, et al.
NPJ Parkinson'S Disease|April 12, 2025
Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaquesMorgane Darricau, Valentine Kulifaj, Marie-Laure Arotcarena, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2013
Lysosomal impairment in Parkinson's diseaseBenjamin Dehay, Marta Martinez-Vicente, Guy A Caldwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2016
Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophyFares Bassil, Pierre-Olivier Fernagut, Erwan Bezard, et al.
Pageof 30

Showing results (181-190 of 298) with videos related to

Sort By:
Pageof 30
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2018
An mGlu4-Positive Allosteric Modulator Alleviates Parkinsonism in PrimatesDelphine Charvin, Therese Di Paolo, Erwan Bezard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's diseaseNikhil M Urs, Simone Bido, Sean M Peterson, et al.
Biological Psychiatry|June 2, 2009
Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson diseaseOlivier Berton, Céline Guigoni, Qin Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2003
Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's diseaseCaroline Prunier, Pierre Payoux, Denis Guilloteau, et al.
Neurobiology of Disease|January 26, 2016
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's diseaseLudovico Arcuri, Riccardo Viaro, Simone Bido, et al.
Plos One|October 23, 2010
Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primateQuentin Barraud, Ibrahim Obeid, Incarnation Aubert, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2012
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegenerationBenjamin Dehay, Alfredo Ramirez, Marta Martinez-Vicente, et al.
NPJ Parkinson'S Disease|April 12, 2025
Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaquesMorgane Darricau, Valentine Kulifaj, Marie-Laure Arotcarena, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2013
Lysosomal impairment in Parkinson's diseaseBenjamin Dehay, Marta Martinez-Vicente, Guy A Caldwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2016
Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophyFares Bassil, Pierre-Olivier Fernagut, Erwan Bezard, et al.
Pageof 30